541522-65-0

Upstream product

• 541522-63-8 methyl (2E)-2-azido-3-{4-[(tert-butoxycarbonyl)amino]phenyl}prop-2-enoate 
• 1049677-82-8 1-(tert-butyl) 2-methyl 6-amino-1H-indole-1,2-dicarboxylate 
• 1093261-18-7 1-(1,1-dimethylethyl) 2-methyl 6-nitro-1H-indole-1,2-dicarboxylate 
• 10242-00-9 6-Nitro-1H-indole-2-carboxylic Acid 
• 136818-66-1 6-Nitro-1H-indole-2-carboxylic acid methyl ester 
• 167027-30-7 methyl 6-amino-1H-indole-2-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 167027-30-7 methyl 6-amino-1H-indole-2-carboxylate 
• 1093255-84-5 6-amino-N-({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-1H-indole-2-carboxamide trifluoroacetate 
• 1093261-29-0 1,1-dimethylethyl (2-{[({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)amino]carbonyl}-1H-indol-6-yl)carbamate 
• 1093261-27-8 6-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-1H-indole-2-carboxylic acid 

Relevant academic research and scientific papers

CHEMICAL COMPOUNDS

The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.

Indole nitriles

Compounds of the formula (I) wherein m, n, R1, R2, R3, R4, R5and R6are as described herein, together with methods for making the compounds and using the compounds for treatment of diseases or conditions mediated by Cathepsin K.

Indole nitriles

Compounds of the formula (I) wherein m, n, R1, R2, R3, R4, R5 and R6 are as described herein, together with methods for making the compounds and using the compounds for treatment of diseases or conditions mediated by Cathepsin K.